UBAP2L and hepatocellular carcinoma: Particularly in hepatocellular carcinoma, UBAP2L overexpression enhances malignant phenotypes, while PRMT1-mediated methylation establishes a dynamic equilibrium between pro-survival SG assembly and the oncogenic functions of methylated UBAP2L [21, 27].